Norihiko Misawa
Osaka, 5458586, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Macrophage immunosenescence prolongs intraocular inflammation in aged mice via impaired induction of regulatory T cells.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
Heterologous Production of 2,2'-Dihydroxy Derivatives of Astaxanthin and Adonirubin in Escherichia coli and Evaluation of Their Antioxidant Activity.
Journal: Antioxidants (Basel, Switzerland)
Published: January 15, 2026
Anterior Suprachoroidal Fluid Following Photodynamic Therapy for Chronic CSC: An Anterior-Segment Optical Coherence Tomography Study.
Journal: Ophthalmology and therapy
Published: January 01, 2026
Heterologous Production of Torularhodin, the Monocyclic Carotenoid with a Terminal Carboxyl Group, in Escherichia coli.
Journal: Biotech (Basel (Switzerland))
Published: November 19, 2025
Gene expression cluster differences and molecular correlation with the STING pathway in orbital MALT lymphoma and orbital IgG4-related eye disease.
Journal: Discover oncology
Published: March 13, 2025
Correlation Between Changes in Extraocular Muscles and Intraocular Pressure Following Anti-Inflammatory Therapy in Active Thyroid Eye Disease.
Journal: Journal of clinical medicine
Published: December 20, 2024
3'-Caffeoylquercetin Glycosides and 4'-Caffeoylkaempferol Glycosides-Novel Antioxidant Flavonoids Discovered in the Freesia Yellow Flowers.
Journal: Antioxidants (Basel, Switzerland)
Published: December 17, 2024
A Case of Branch Retinal Artery Occlusion With Concomitant Intraocular and Extraocular Toxoplasmosis Lesions in a Japanese Man.
Journal: Case reports in ophthalmological medicine
Published: December 05, 2024
Serum PD-1 regulation and PD-1 expression of CD4+Foxp3+ regulatory T cells in patients in thyroid eye disease associated with immunosuppression treatment.
Journal: Frontiers in ophthalmology
Published: September 04, 2024
One-Year Outcome of Intravitreal Injection of Ranibizumab Biosimilar for Myopic Choroidal Neovascularization in Japanese Patients.
Journal: Journal of clinical medicine
Published: July 10, 2024
Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment Responsiveness.
Journal: Journal of clinical medicine
Published: June 27, 2024
Last Updated: 09/26/2026